Inogen (INGN): Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Inogen, Inc. (INGN) - corporate logo

Current liquidity for Inogen, Inc. (INGN) is limited due to process restructuring, necessitating strict cost control amid the implementation of eco-standards and energy-saving technologies in production. This chart illustrates a market valuation of EV/EBITDA at 0.00. Inogen, Inc. (INGN) generates revenue through the creation of portable oxygen systems, leveraging rising demand among the elderly and the shift of patients toward home respiratory therapy.

Inogen Inc - INGN Company Value to EBITDA (period 11/23/2025 - 11/10/2026)

Metric breakdowns and analytics for inogen.com (INGN)

- current price and projected stock value:
Stock Price Inogen|INGN - Analyst Consensus Forecast
- stock exchange capitalization data:
Market Value INGN|INGN - Business Value
- book value of equity indicators:
Book Value per Share Inogen, Inc.|INGN - Total Stockholders' Equity|Market Value to Book Value Ratio inogen.com|INGN - Company Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio Inogen, Inc.|INGN - Long-Term Debt to Capital|Short-Term Debt to Equity Inogen|INGN - Company Total Debt Obligations|Debt to Book Value INGN|INGN - Company Long-Term Loans and Borrowings|Company Short-Term Debt Inogen, Inc.|Quick Ratio inogen.com
- financial results and valuation multiples details:
INGN - Company Net Income|Projected Future Earnings Inogen, Inc.|INGN - Price to Earnings Multiple|Forward P/E Multiple Inogen|INGN - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple INGN|INGN - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Inogen, Inc.|INGN - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months inogen.com|INGN - Earnings per share growth in current year|Expected earnings per share growth for next year Inogen, Inc.
Comprehensive company analysis:Inogen Medical (INGN)
Manufactured products of Inogen

Inogen, Inc. (INGN) relies on stable demand for portable oxygen concentrators, rendering the business capital-intensive and mature. The EV/EBITDA metric correlates the total enterprise value with its operating profit before depreciation and interest. It is critical for investors to monitor this ratio to identify asset undervaluation amid market stagnation. Analyzing the EV/EBITDA ratio of Inogen, Inc. (INGN) within a historical context helps determine an entry point amidst the risk of margin compression.

Key competitors

EV/EBITDA Multiple SYK (Stryker Inc)|EV/EBITDA Multiple Medtronic Corp MDT|PHG - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SNN (smith-nephew.com) - Enterprise Value to Operating Income Before Depreciation|HOLX: EV/EBITDA Multiple|Company Value to EBITDA Carlisle Companies Incorporated (CSL)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Greatbatch|Company Value to EBITDA LivaNova Corp LIVN|Enterprise Value to EBITDA Ratio AHCO (AdaptHealth Corp.)|EV/EBITDA Multiple SS Innovations International, Inc. (SSII)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avanos Medical AVNS|Total Company Value to Operating Income Before Depreciation Ratio Shoulder Innovations, Inc. (SI)|VMD: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation OWLT (Owlet, Inc.)|Quipt Home Medical (QIPT) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Precision Optics Corporation|PAVM (PAVmed, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA Tivic Health Systems, Inc. TIVC|EV/EBITDA Multiple MOVE|Nuvo Group Ltd - Enterprise Value to Operating Income Before Depreciation